Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 761-772
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Therapy | 2010-2014, 154 patients | 2015-2019, 174 patients | All patients, 328 |
Surgical resection | 3 (2) | 5 (3) | 8 (2) |
Percutaneous radiofrequency ablation | 31 (20) | 25 (14) | 56 (17) |
TACE | 58 (38) | 66 (38) | 124 (38) |
SIRT | 13 (8) | 33 (19) | 46 (14) |
Sorafenib | 11 (7) | 6 (3) | 17 (5) |
Palliation | 38 (25) | 39 (22) | 77 (23) |
- Citation: Bracco C, Gallarate M, Badinella Martini M, Magnino C, D'Agnano S, Canta R, Racca G, Melchio R, Serraino C, Polla Mattiot V, Gollè G, Fenoglio L. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World J Gastrointest Oncol 2024; 16(3): 761-772
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/761.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.761